← All Sonim Technologies INC filings

Sonim Technologies INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
SONM
Sonim Technologies INC
10-K: DNA X Shifts Focus to Crypto Trading After Divesting Phone Business
DNA X, Inc. has completed the sale of its legacy phone and hotspot business and is now fully focused on its cryptocurrency trading platform, DNA X, while addressing going concern uncertainties.
NASDAQ
SONM
Sonim Technologies INC
10-K/A: Sonim Technologies Files Amendment to 10-K, Addressing Proxy Statement Delay and Updating Executive Certifications
Sonim Technologies files an amendment to its annual report on Form 10-K to include information typically found in the proxy statement, which will be filed later than expected, and to provide updated certifications from its principal executive and financial officers.
NASDAQ
SONM
Sonim Technologies INC
10-K: Sonim Technologies Reports Strategic Shift and Anticipates Revenue Growth in 2025
Sonim Technologies transitions from low-margin white label products, anticipates revenue growth in 2025 with new product launches, and focuses on expanding its rugged enterprise and public sector markets.
NASDAQ
SONM
Sonim Technologies INC
10-K/A: Sonim Technologies Files Amended Annual Report, Updates Executive and Director Information
Sonim Technologies has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and related matters.
NASDAQ
SONM
Sonim Technologies INC
10-K: Sonim Technologies Reports Fiscal Year 2023 Results, Highlights Strategic Expansion and Product Wins
Sonim Technologies reports a significant increase in revenue and a shift to near breakeven for fiscal year 2023, driven by new product launches and strategic market expansion.